MDQK.HM MediNavi AG (HAM) up 200% on 28 Jan 2026: check volume drivers
MDQK.HM stock jumped 200.00% to €7.50 on 28 Jan 2026 during market hours on the HAM exchange in Germany. The move came from an opening price of €2.50 and a day high of €7.50, on volume of 35 shares versus an average volume of 41. Traders flagged the sharp percentage gain despite low absolute liquidity, so short-term momentum and news flow will determine whether this is a genuine breakout or a thin-market squeeze.
MDQK.HM stock: Intraday price and volume snapshot
MDQK.HM stock closed at €7.50 on 27 Jan 2026 after a €5.00 intraday jump. The previous close was €2.50. Volume totaled 35 shares, below the 50-day average of 41. The relative volume equals 0.85, which signals thin trading and possible price distortion from a small number of trades.
MDQK.HM stock: Fundamentals and ratios
MediNavi AG operates in Healthcare, Medical – Healthcare Information Services, listed on HAM in Germany. Key ratios show a current ratio of 41.50 and interest coverage of -1362.59, reflecting negligible operating earnings. Price averages are €2.50 (50-day) and €2.00 (200-day). Enterprise value over EBITDA sits at 2.17. Earnings per share and PE are not available, so valuation must rely on balance-sheet metrics.
MDQK.HM stock: Technical and liquidity signals
Technical indicators show a high intraday swing with ATR €5.00, reflecting volatility. RSI and MACD are not meaningful due to sparse trading history. The low average volume and the day’s volume of 35 shares create wide bid-ask spreads and high execution risk. Price averages rising from €1.99 to €2.50 over 200 and 50 days suggest recent interest, but liquidity remains the main constraint for active traders.
MDQK.HM stock: Catalysts, news and sector context
No formal earnings or corporate announcements were listed at the time of the move. MediNavi AG’s website lists its platform for doctor search and second opinions. In Healthcare, peers show muted 1Y performance versus Tech, so sector tailwinds are limited. Check official sources for filings and the company site MediNavi website for updates before trading.
MDQK.HM stock: Risks and trading checklist
Primary risks include extreme price swings on low volume, limited public financial data, and absence of EPS and PE metrics. Market makers may widen spreads and order execution can be unreliable. For intraday traders, set tight size limits and stop-loss rules. For longer-term investors, demand audited financials and clear revenue guidance before increasing exposure.
MDQK.HM stock: Meyka grade and analyst framework
Meyka AI rates MDQK.HM with a score out of 100. Score: 58.66 | Grade: C+ | Suggestion: HOLD. This grade factors S&P 500 and sector benchmarks, industry comparison, financial growth, key metrics, and analyst consensus. The score reflects weak operating metrics but some balance-sheet padding. These grades are informational only and not investment advice. For more context, view our Meyka page MediNavi on Meyka.
Final Thoughts
Key takeaways: MDQK.HM stock posted a 200.00% rise to €7.50 on 28 Jan 2026 during regular HAM trading, but the gain occurred on 35 shares and a relative volume of 0.85, indicating thin liquidity and execution risk. Fundamentals are sparse: EPS and PE are not available, current ratio is 41.50, and enterprise-value-to-EBITDA is 2.17, which suggests asset backing but little operating profitability. Meyka AI’s forecast model projects a 12-month base case of €5.00, versus the current €7.50, implying a downside of -33.33%. Forecasts are model-based projections and not guarantees. Short-term traders may find momentum opportunities, but longer-term investors should demand clearer revenue growth, public guidance, and higher average daily volume before increasing position size. Use strict risk controls and confirm any corporate news on the company website and official filings.
FAQs
Why did MDQK.HM stock spike 200% on 28 Jan 2026?
The spike to €7.50 came on thin volume of 35 shares. No earnings release was listed. Small trades can move the price sharply in low-liquidity stocks. Confirm corporate news on the company site before assuming a sustainable trend.
What is Meyka AI’s grade for MDQK.HM stock and what it means?
Meyka AI rates MDQK.HM 58.66 out of 100, grade C+, suggestion HOLD. The grade compares sector and S&P benchmarks, financial growth, key metrics, and analyst signals. It is informational and not financial advice.
What price target does Meyka AI give for MDQK.HM stock?
Meyka AI’s forecast model projects a 12-month base case price of €5.00 versus the current €7.50, implying -33.33%. Forecasts are model-based projections and not guarantees.
Is MDQK.HM stock liquid enough for active trading?
No. Average volume is 41 shares and day volume was 35, producing wide spreads and execution risk. Active traders should limit size and use limit orders on this thinly traded HAM stock.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
